Connect your AI

Lantheus Holdings LNTH 2028

2028 at other companies

Mirum Pharmaceuticals, Inc.MIRM

——

Guardant HealthGH

——

RevvityRVTY

——

ImmunityBio, Inc.IBRX

——

Labcorp HoldingsLH

——

Agilent TechnologiesA

——

Other financials

Income statement

Revenue$377.3M+1.2%

Gross profit$230.9M-2.9%

Operating income$81.3M-20.3%

Net income$118.4M+62.3%

EPS (diluted)$1.80+76.5%

Balance sheet

Cash & equivalents$500.3M-46.8%

Total debt$627.9M+1.8%

Total equity$1.2B+4.1%

Total assets$2.3B+14.2%

Cash flow

Operating cash flow$125.1M+16.3%

CapEx$3.2M-63.0%

Free cash flow$121.9M+23.3%

Valuation

Market cap$6.76B-26.3%

Enterprise value$6.89B-20.5%

P/E24.2×-10.2×

P/S4.4×-1.6×

Profitability

Gross margin60.5%-3.6pp

Operating margin18.8%-10.7pp

Net margin18%+0.7pp

FCF margin24.4%-6.4pp

Returns & leverage

Return on equity23.5%-1.7pp

Debt / equity0.5×0.0×

Current ratio2.8×-2.9×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Lantheus Holdings's 2028?: Lantheus Holdings (LNTH) reported 2028 of $58.07M in Q1 2026.
How has Lantheus Holdings's 2028 changed year-over-year?: Lantheus Holdings's 2028 increased by 112.5% year-over-year, from $27.34M to $58.07M.